eight – Page 3 – Communicable Diseases Research

Evaluation of the systemic and mucosal immune response induced by COVID-19 and the BNT162b2 mRNA vaccine for SARS-CoV-2

Article

Published on 2022-10-182022-11-15
Journal: PLoS ONE [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술,

[키워드] antibody antibody production appear BNT162b2 BNT162b2 mRNA vaccine convalescent correlated COVID-19 COVID-19 patients decrease detectable eight elicit functional generate Heterologous humoral humoral immune response Immunity immunization increase induce marker mRNA vaccination mRNA vaccine mucosal mucosal immune NAb Neutralizing neutralizing capacity of BNT162b2 omicron peaked progression proportion protective immune response RBD RBD-binding antibody reduced Saliva SARS-CoV-2 second dose second vaccination sera significantly Spike protein subsequent the RBD the S1 subunit the SARS-CoV-2 vaccinated individual vaccination Vaccine vaccinee vaccinees variant virus neutralizing titers VoC VOCs wildtype
[DOI] 10.1371/journal.pone.0263861 PMC 바로가기

The impact of COVID-19 on implementation of mass testing, treatment and tracking of malaria in rural communities in Ghana: A qualitative study

가나 농촌 지역사회에서 말라리아 대량 검사, 치료 및 추적 실시에 대한 코로나19의 영향: 질적 연구

Article

Published on 2022-10-132022-11-15
Journal: PLoS ONE [Category] 말라리아, 진단,

Targeting SARS-CoV-2 Main Protease for Treatment of COVID-19: Covalent Inhibitors Structure-Activity Relationship Insights and Evolution Perspectives

Article

Published on 2022-10-132022-11-15
Journal: Journal of medicinal chemistry [Category] COVID19(2023년), SARS, 치료제,

In vitro testing of salt coating of fabrics as a potential antiviral agent in reusable face masks

Article

Published on 2022-10-112022-11-15
Journal: Scientific Reports [Category] COVID19(2023년), SARS, 치료제,

Systematic Down-Selection of Repurposed Drug Candidates for COVID-19

Article

Published on 2022-10-062022-11-15
Journal: International Journal of Molecular Sciences [Category] COVID19(2023년), SARS, 변종, 신약개발, 치료제,

Evidence for the heterologous benefits of prior BCG vaccination on COVISHIELD™ vaccine-induced immune responses in SARS-CoV-2 seronegative young Indian adults

Article

Published on 2022-10-042022-11-16
Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 변종,

[키워드] Activation Adaptive immune response antibodies antibody BCG BCG vaccination benefit booster breadth CD4+ CD8+ T-cell changes changes in chromatin Combination COVID-19 vaccines Delta Effect effector memory eight elevated ENhance Epigenetic Evidence expressing greater Heterologous highlighting IL-1β IL-2 immune response Immunity in-depth analysis India marker memory T-cell response mutant NAb Neutralizing provide revaccination SARS-CoV-2 seronegative significantly higher subset T cell T-cell Response tested TNF-α TNF-α expression trained immunity Tuberculosis vaccination Vaccine vaccine-induced immune response
[DOI] 10.3389/fimmu.2022.985938 PMC 바로가기

Adverse events following immunization of elderly with COVID-19 inactivated virus vaccine (CoronaVac) in Southeastern Brazil: an active surveillance study

Article

Published on 2022-10-032022-11-15
Journal: Revista do Instituto de Medicina Tropical de São [Category] 진단,

Care for adults with COVID-19: living guidelines from the National COVID-19 Clinical Evidence Taskforce

Article

Published on 2022-10-032022-11-15
Journal: The Medical journal of Australia [Category] COVID19(2023년), SARS, 진단,

[키워드] Analysis anticoagulation Antiviral agents Baricitinib benefit change clinical clinical trial Combination coronavirus disease Corticosteroids COVID-19 disease disease severity drug treatment eight Endotracheal intubation Evidence facilitated Health include Inhaled maintain management Mild molnupiravir nine Patient people with COVID-19 positive airway pressure Primary Health Care prone positioning Prophylactic Prophylaxis Public public health randomised recommendation recommendations Remdesivir Respiratory Support sarilumab subsequent supplemental oxygen Support supportive care systemic corticosteroids therapy Tocilizumab Treatment trials Venous Thromboembolism with COVID-19
[DOI] 10.5694/mja2.51718 PMC 바로가기

Environmental detection of SARS-CoV-2 in hospital rooms in different wards of a university hospital

Article

Published on 2022-10-012022-11-15
Journal: The Journal of hospital infection [Category] COVID19(2023년), SARS, 치료기술,

External quality assessment of SARS-CoV-2 serology in European expert laboratories, April 2021

Article

Published on 2022-10-012022-11-15
Journal: Eurosurveillance [Category] COVID19(2023년), SARS, 진단, 치료기술,

[키워드] anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody antibodies characterisation collected composed country COVID-19 Critical detect Diagnosis diagnostics eight epidemiological EQA Europe European evaluate External human SARS-CoV-2 human serum immune response Immunoglobulin indicated involved Laboratory mitigate natural infection neutralising antibody participant performed provided public health measures robust SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 antibody responses SARS-COV-2 infection SARS-CoV-2 pandemic SARS-CoV-2 transmission Sensitivity and specificity serological serological test serology Support the vaccine Vaccine
[DOI] 10.2807/1560-7917.ES.2022.27.42.2101057 PMC 바로가기